02.05.2024 - KT-474/SAR444656 (IRAK4) Phase 2 clinical trials ongoing in HS and ADÂ with data expected in the first half of 2025 KT-621 (STAT6) expected to start Phase 1 in the second half of 2024 and KT-294 (TYK2) expected to start Phase 1 in the first half of .
BMC Series blog Introducing BMC Biomedical Engineering s Collection: Point-of-care diagnostics biomedcentral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biomedcentral.com Daily Mail and Mail on Sunday newspapers.